REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Arxada Biotec S.R.O. (Czech Republic)

Main Activities: Pharmaceutical and Medicine Manufacturing | Other Chemical Product and Preparation Manufacturing
Full name: Arxada Biotec S.R.O. Profile Updated: February 28, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Arxada Biotec S.R.O. is an enterprise located in Czech Republic, with the main office in Kourim. The company operates in the Pharmaceutical and Medicine Manufacturing sector. The company was established on April 27, 1992. It currently has a total number of 200 - 249 (2025) employees. The company’s latest financial report indicates a net sales revenue drop of 23.07% in 2024. Its’ total assets recorded a negative growth of 6.39%. The enterprise’s net profit margin decreased by 7.01% in 2024.

Headquarters
Okruzni 134
Kourim; Stredocesky; Postal Code: 28161

Contact Details: Purchase the Arxada Biotec S.R.O. report to view the information.

Website: https://www.lonza.com/cz

Basic Information
Total Employees:
Purchase the Arxada Biotec S.R.O. report to view the information.
Registered Capital:
Purchase the Arxada Biotec S.R.O. report to view the information.
Financial Auditors:
Purchase the Arxada Biotec S.R.O. report to view the information.
Incorporation Date:
April 27, 1992
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Chairman of the Supervisory Board
Purchase this report to view the information.
Member of the Supervisory Board
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Arxada Biotec S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-23.07%▼
Total Operating Revenue
-28.46%▼
Operating Profit
-53.17%▼
EBITDA
-57.49%▼
Net Profit/Loss for the Period
-71.86%▼
Total Assets
-6.39%▼
Total Equity
1.65%▲
Operating Profit Margin
-3.65%▼
Net Profit Margin
-7.01%▼
Return on Equity (ROE)
-4.24%▼
Quick Ratio
2.24%▲
Cash Ratio
-0.1%▼

Similar companies

Zentiva, K.S.
 
Novartis S.R.O.
Teva Czech Industries S.R.O.
 
Novavax Cz A.S.
Hartmann - Rico A.S.
 
Lohmann & Rauscher, S.R.O.
Biomedica, Spol. S R.O.
 
Vuab Pharma A.S.
Imunomedica, A.S.
 
Cayman Pharma S.R.O.
Noventis S.R.O.
 

Related EMIS Industry Reports

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo